Advertisement
Advertisement
Aldurazyme

Aldurazyme Warnings

Manufacturer:

Sanofi

Distributor:

DKSH
Full Prescribing Info
Warnings
Hypersensitivity Reactions Including Anaphylaxis: Patients treated with ALDURAZYME have experienced life-threatening hypersensitivity reactions including anaphylaxis. Appropriate medical monitoring and support measures, including cardiopulmonary resuscitation equipment, should be readily available during ALDURAZYME administration. If a severe hypersensitivity reaction (e.g., anaphylaxis) occurs, discontinue ALDURAZYME immediately and initiate appropriate medical treatment. In patients with severe hypersensitivity reactions, a desensitization procedure to ALDURAZYME may be considered (see Precautions).
Acute Respiratory Complications Associated with Administration: Patients with compromised respiratory function or acute respiratory disease may be at risk of serious acute exacerbation of their respiratory compromise due to infusion reactions and require additional monitoring (see Acute Respiratory Complications Associated with Administration under Precautions).
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement